|
MCID: MCP020
|
Mucopolysaccharidosis Type Iiic malady |
|
Sources: 30NIH Rare Diseases, 22MalaCards See all sources Export this MalaCard |
NIH Rare Diseases: Mucopolysaccharidosis type IIIC (MPS IIIC) is an genetic disorder that makes the body unable to break down large sugar molecules called glycosaminoglycans (GAGs, formerly called mucopolysaccharides). Specifically, people with this condition are unable to break down a GAG called heparan sulfate. Affected individuals can have severe neurological symptoms, including progressive dementia, aggressive behavior, hyperactivity, seizures, deafness, loss of vision, and an inability to sleep for more than a few hours at a time. MPS IIIC results from the missing or altered enzyme acetyl-CoAlpha-glucosaminide acetyltransferase. This condition is inherited in an autosomal recessive manner. There is no specific treatment. Most people with MPS IIIC live into their teenage years; some live longer.30
MalaCards: Mucopolysaccharidosis Type Iiic, also known as sanfilippo syndrome c, is related to mucopolysaccharidosis type iiic (sanfilippo c) and mucopolysaccharidosis iii. An important gene associated with Mucopolysaccharidosis Type Iiic is HGSNAT (heparan-alpha-glucosaminide N-acetyltransferase). |
|
Sources: 30NIH Rare Diseases, 16GeneTests, 43UMLS See all sources |
|
Sources: 13GeneCards, 14GeneDecks See all sources |
Disease types for mucopolysaccharidosis family:Diseases related to mucopolysaccharidosis type iiic by text searches and GeneDecks gene sharing:
|
|
|
|
Sources: 4CenterWatch, 29NIH Clinical Center, 5ClinicalTrials See all sources |
Approved drugs:Search CenterWatch for mucopolysaccharidosis type iiic Drug clinical trials:Search ClinicalTrials for mucopolysaccharidosis type iiic Search NIH Clinical Center for mucopolysaccharidosis type iiic Search CenterWatch for mucopolysaccharidosis type iiic |
|
Sources: 16GeneTests See all sources |
|
|
|
|
|
|
|
Sources: 1BioGPS See all sources |
![]() |
|
|
|
|
|
|
